微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2.99% | 19.12% | -50.74% | 23/139 | 1.16% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 6.07% | -41.91% | -37.55% | 47/139 | 2.07% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 9.72% | 19.56% | 85.14% | 20/139 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 5.25% | 0.19% | 109.16% | 24/139 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 2.51% | -13.45% | -75.98% | 31/139 | 1.04% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 10.45% | 112.4% | 28.54% | 27/139 | 3.02% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 8.13% | 71.16% | 55.15% | 31/139 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 5.24% | -1.69% | 80.69% | 36/139 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 2.9% | -28.22% | -41.06% | 28/139 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 4.92% | -76.77% | 3.58% | 72/139 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 4.75% | -32.24% | -10.88% | 66/139 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 5.33% | -49.72% | 31.93% | 41/139 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 4.04% | -27.47% | -80.93% | 23/139 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 21.18% | 69.98% | 202.14% | 22/139 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 7.01% | -38.45% | -33.87% | 71/139 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 10.6% | 68.79% | 90.31% | 31/139 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 5.57% | 50.54% | -55.3% | 25/139 | 6.21% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 12.46% | -69.11% | 9.39% | 68/139 | 17.28% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 11.39% | -67.92% | 81.37% | 52/139 | 15.82% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 6.28% | -73.81% | 69.73% | 68/139 | 11.46% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 3.7% | -9.31% | -90.83% | 43/139 | 6.18% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 40.34% | 168.4% | 13.6% | 22/139 | 25.47% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 35.51% | 131.64% | 48.08% | 13/139 | 19.63% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 23.98% | 222.75% | 487.75% | 19/139 | 15.03% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 4.08% | 4.88% | -72.85% | 22/139 | 3.37% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 15.03% | -12.21% | -1.96% | 56/139 | 14.24% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 15.33% | 42.08% | 106.33% | 13/139 | 10.37% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 7.43% | -31.08% | 91% | 26/139 | 6.65% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 3.89% | 2% | -77.28% | 13/139 | 2.68% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 17.12% | -8.94% | 58.67% | 42/139 | 12.87% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 10.79% | 2% | -42.61% | 20/139 | 7.11% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2017-12-31 | 18.8% | -8.87% | 74.4% | 33/139 | 13.76% | *ST明德 | 14.54% | 行业排名> |
| 2017-06-30 | 10.78% | 2% | -47.75% | 10/139 | 5.88% | 迈瑞医疗 | 11% | 行业排名> |
| 2016-12-31 | 20.63% | 2% | 2% | 23/139 | 16.11% | 安旭生物 | 59.22% | 行业排名> |